BMJ Case Reports 2017; doi:10.1136/bcr-2016-217855
  • Unexpected outcome (positive or negative) including adverse drug reactions

Use of cabergoline for the management of persistent Cushing’s disease in pregnancy

  1. Kok Onn Lee
  1. Department of Medicine, National University Hospital, Singapore, Singapore
  1. Correspondence to Dr Kathleen Su-Yen Sek, kathleen_sy_sek{at}
  • Accepted 16 June 2017
  • Published 14 July 2017


Cushing’s disease (CD) is rare during pregnancy and is associated with significant maternal and fetal complications. It is important to control hypercortisolism during pregnancy, either surgically or medically, for a successful maternal and fetal outcome. We report a patient with recurrent CD who was treated with low-dose cabergoline (CAB) for persistent hypercortisolism throughout pregnancy. A 36-year-old woman was diagnosed with CD at the age of 23. She underwent trans-sphenoidal surgery with initial complete remission. However, 4 years after surgery, CD recurred and she underwent Gamma Knife radiosurgery (GKRS). Following GKRS, her cortisol levels remained elevated despite no evidence of visible tumour on pituitary MRI. Medical treatment was commenced with ketoconazole and cyproheptadine. This was changed to CAB as she was keen for pregnancy. She conceived spontaneously and was on CAB throughout pregnancy. She delivered a healthy male neonate, weighing 3195 g at 40 weeks of gestation.


  • Contributors KO was involved in the care of the patient and conceived this study. KSS wrote the first draft. KSS, DSD and KOL reviewed and revised the draft. All authors approved the submitted version of the manuscript.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article